Assessing the role of venetoclax in combination with hypomethylating agents in higher risk myelodysplastic syndrome by Rami S. Komrokji, Avani M. Singh, Najla Al Ali, Onyee Chan, Eric Padron, Kendra Sweet, Andrew Kuykendall, Jeffrey E. Lancet, David A. Sallman

Get full text